(HealthDay News) — Here are the latest clinical trials, courtesy of ClinicalConnection.com:
Emphysema/COPD
This study will evaluate the effects of an investigational drug on people with emphysema.
The research site is in Richmond, Va.
More information
Please see http://www.clinicalconnection.com/clinical_trials/condition/copd.aspx.
—–
Alzheimer’s Disease (Ages 50-89)
The study will evaluate the safety, effectiveness, and tolerability of an investigational drug to treat mild-to-moderate Alzheimer’s disease.
The research site is in Philadelphia, Penn.
More information
Please see http://www.clinicalconnection.com/clinical_trials/condition/alzheimer’s_disease.aspx.
—–
Ovarian Cancer
This study will evaluate the investigational drug farletuzumab, given in combination with carboplatin and taxane, for women with relapsed platinum-sensitive epithelial ovarian cancer.
The research site is in Louisville, Ky.
More information
Please see http://www.clinicalconnection.com/clinical_trials/condition/ovarian_cancer.aspx.
—–
Copyright 2011 ClinicalConnection.com. All rights reserved.